Physician profile
Mindy M Plotkin
NPI 1588742050
$2,117.01
in general payments reported to CMS, 2019-2025
23 companies · $505 in 2025
The $505 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.73 · 2020: $79.06 · 2021: $344 · 2022: $365 · 2023: $499 · 2024: $240 · 2025: $505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,144 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,143.97 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $283.03 | 2023-2025 | |
| Astellas Pharma US INC | $251.47 | 2023-2024 | Veozah |
| Therapeuticsmd, INC. | $249.51 | 2020-2022 | |
| Abbvie INC. | $237.50 | 2020-2023 | |
| Exeltis, USA INC. | $208.12 | 2023-2025 | Slynd |
| Merck Sharp & Dohme LLC | $160.67 | 2019-2022 | |
| Hologic Sales and Service, LLC | $108.78 | 2021-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $101.46 | 2020-2023 | |
| Myovant Sciences INC. | $80.75 | 2022 | |
| Evofem Biosciences, INC. | $74.91 | 2024 | |
| Millicent US INC | $44.79 | 2025 | Femlyv |
| Exact Sciences Corporation | $41.69 | 2024-2025 | Cologuard Collection Kit |
| Pfizer INC. | $40.26 | 2023 | |
| Organon LLC | $39.25 | 2023-2025 | Nexplanon |
| Agile Therapeutics, INC. | $35.71 | 2022-2024 | Twirla |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $29.43 | 2025 | Zurzuvae |
| Daiichi Sankyo INC. | $26.95 | 2022 | |
| Shield Therapeutics INC | $24.95 | 2024 | |
| Coopersurgical, INC. | $19.42 | 2022 | |
| Mylan Pharmaceuticals INC. | $18.47 | 2021 | |
| Ascend Therapeutics US, LLC | $14.29 | 2022 | |
| Meditrina | $12.82 | 2025 | |
| Avion Pharmaceuticals | $12.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mindy Plotkin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.